Back to search
Anticoagulant Therapy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Anticoagulant Therapy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Anticoagulant Therapy trials you may qualify forVenous thromboembolism (VTE) and atherosclerotic cardiovascular disease share common risk factors and frequently coexist in the same patients. Their management…
This registry, currently being established will ensure consistency of data collection and provide safety information in non high-risk APS patients currently on…
End-stage renal disease (ESRD) is a growing global health burden, and the creation of a native arteriovenous fistula (AVF) is the gold standard for vascular acc…
In patients with Behçet's syndrome (BS), deep venous thrombosis (DVT) is thought to result from inflammation of the vessel wall rather than hyper coagulability.…
This is a single-center, randomized, open-label, parallel-controlled clinical trial designed to investigate the anticoagulation efficacy and safety of different…
This is a feasibility study of uninterrupted warfarin with a one time dose of Vitamin K before a surgical procedure.
The primary aim of this study is to describe and develop a cross-sectional profile of the level of the main health determinants in the Italian anticoagulated po…
This is a Phase 3, multicenter, open-label, blinded endpoint study to evaluate the effect of abelacimab relative to dalteparin on venous thromboembolism (VTE) r…
The study seeks to fill the gaps regarding safety and efficacy of rivaroxaban and standard anticoagulant. therefore the current study was planned with the aim t…